Global PDF: US$ 4,100.00
A strategic assessment of Clariant, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.
Contains 41 pages and 5 tables
A strategic assessment of Clariant, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.
Contains 41 pages and 5 tables
I. EXECUTIVE SUMMARY
II. BUSINESS ORGANIZATION
III. SENIOR MANAGEMENT
IV. FACILITIES AND EMPLOYEES
V. TECHNOLOGICAL KNOW-HOW
VI. PRODUCT PORTFOLIO
VII. MARKETING TACTICS
VIII. SALES AND PROFIT GROWTH
IX. R&D EXPENDITURES AND MAJOR PROGRAMS
X. COLLABORATIVE ARRANGEMENTS
XI. STRATEGIC DIRECTION
LIST OF TABLES
Table 1: Clariant Sales by Division
Table 2: Clariant Sales Growth by Division
Table 3: Clariant Profit by Division
Table 4: Clariant Profit Growth by Division
Table 5: Clariant Sales by Geographic Region
Skip to top
II. BUSINESS ORGANIZATION
III. SENIOR MANAGEMENT
IV. FACILITIES AND EMPLOYEES
V. TECHNOLOGICAL KNOW-HOW
VI. PRODUCT PORTFOLIO
VII. MARKETING TACTICS
VIII. SALES AND PROFIT GROWTH
IX. R&D EXPENDITURES AND MAJOR PROGRAMS
X. COLLABORATIVE ARRANGEMENTS
XI. STRATEGIC DIRECTION
LIST OF TABLES
Table 1: Clariant Sales by Division
Table 2: Clariant Sales Growth by Division
Table 3: Clariant Profit by Division
Table 4: Clariant Profit Growth by Division
Table 5: Clariant Sales by Geographic Region
DSM: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
US$ 1,615.00
Oct, 2010 · 46 pages
BASF: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
US$ 1,572.50
Oct, 2010 · 73 pages
Evonik: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
US$ 1,615.00
Oct, 2010 · 45 pages
Lanxess: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
US$ 1,615.00
Oct, 2010 · 43 pages
Cambrex: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
US$ 1,615.00
Oct, 2010 · 56 pages
